BMY vs RM · P/E 17, rev $48.19B vs P/E 7.5, rev $588.5M
Bristol-Myers Squibb Company (BMY) versus Regional Management Corp (RM) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Regional Management Corp (RM) is a credit services company listed on NYSE.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported RM revenue for 2024-12-31 was $588.5M. Net income was $41.2M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. RM currently screens at market cap $339.8M and trailing P/E 7.5.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. RM currently screens at market cap $339.8M and trailing P/E 7.5.
Not investment advice. Open the BMY and RM stock pages for the full models.
Not investment advice.